The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to confirm the safety and efficacy of FCH-PET/CT and to
establish our ability to reproduce results from the literature using FCH-PET/CT as a
diagnostic and decision making tool in the management in two predefined groups of prostate
cancer patients, specifically, biochemical recurrence and high risk staging. The primary
endpoints of the study are the incidence of adverse events (AE) in the study population up to
24 hours following the scan, and the sensitivity and specificity of FCH-PET/CT vs CT on a
per-patient and per-lesion basis.